Cara Therapeutics
CARA
#10358
Rank
NZ$13.56 M
Marketcap
NZ$8.90
Share price
-2.56%
Change (1 day)
2.97%
Change (1 year)

Market capitalization of Cara Therapeutics (CARA)

Market cap: NZ$13.56 Million

As of February 2026 Cara Therapeutics has a market cap of NZ$13.56 Million. This makes Cara Therapeutics the world's 10358th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Cara Therapeutics from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$13.56 M-3.13%
2025NZ$14 M-61.91%
2024NZ$36.76 M-42.56%
2023NZ$64 M-92.96%
2022NZ$0.90 B-4.65%
2021NZ$0.95 B-8.77%
2020NZ$1.04 B-6.5%
2019NZ$1.11 B45.81%
2018NZ$0.76 B36.38%
2017NZ$0.56 B53.59%
2016NZ$0.36 B-45.5%
2015NZ$0.67 B131.4%
2014NZ$0.29 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$977.42 B 7,205,036.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$253.43 B 1,868,134.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
NZ$0.01 M-99.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Recro Pharma
REPH
NZ$0.20 B 1,419.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
NZ$0.76 B 5,558.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
NZ$1.37 M-89.88%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
NZ$24.38 M 79.75%๐Ÿ‡บ๐Ÿ‡ธ USA